Healthcare provider profile · identity verified

Joseph W Hinterberger, MD

Family Practice · DUNDEE, NY · NPI 1326043464

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	493	106
Lisinopril	Lisinopril	474	140
Rosuvastatin Calcium	Rosuvastatin Calcium	298	85
Atorvastatin Calcium	Atorvastatin Calcium	257	74
Omeprazole	Omeprazole	255	83
Amlodipine Besylate	Amlodipine Besylate	215	68
Metoprolol Succinate	Metoprolol Succinate	183	64
Metformin Hcl	Metformin Hcl	176	46
Albuterol Sulfate Hfa	Albuterol Sulfate	133	40
Tamsulosin Hcl	Tamsulosin Hcl	127	34
Jardiance	Empagliflozin	126	34
Pantoprazole Sodium	Pantoprazole Sodium	118	27
Bupropion Xl	Bupropion Hcl	109	29
Metformin Hcl Er	Metformin Hcl	103	32
Metoprolol Tartrate	Metoprolol Tartrate	103	29
Gabapentin	Gabapentin	98	20
Simvastatin	Simvastatin	94	26
Hydrochlorothiazide	Hydrochlorothiazide	93	31
Losartan Potassium	Losartan Potassium	93	26
Tramadol Hcl	Tramadol Hcl	83	18
Alprazolam	Alprazolam	74	16
Montelukast Sodium	Montelukast Sodium	73	21
Allopurinol	Allopurinol	72	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	69	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	66	20
Paroxetine Hcl	Paroxetine Hcl	66	15
Trulicity	Dulaglutide	65	12
Chlorthalidone	Chlorthalidone	64	20
Famotidine	Famotidine	64	15
Pravastatin Sodium	Pravastatin Sodium	62	18
Fluoxetine Hcl	Fluoxetine Hcl	61	14
Carvedilol	Carvedilol	58	16
Warfarin Sodium	Warfarin Sodium	56	11
Eliquis	Apixaban	54	17
Clonazepam	Clonazepam	49	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	48	11
Meloxicam	Meloxicam	48	13
Pregabalin	Pregabalin	47	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Sertraline Hcl	Sertraline Hcl	43	13
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	41	17
Glimepiride	Glimepiride	39	15
Potassium Chloride	Potassium Chloride	39	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Buspirone Hcl	Buspirone Hcl	37	suppressed
Furosemide	Furosemide	37	suppressed
Finasteride	Finasteride	35	11
Fenofibrate	Fenofibrate Nanocrystallized	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Irbesartan	Irbesartan	33	suppressed
Atenolol	Atenolol	32	13
Ezetimibe	Ezetimibe	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	13
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	31	suppressed
Trazodone Hcl	Trazodone Hcl	31	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Divalproex Sodium Er	Divalproex Sodium	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Prednisone	Prednisone	24	16
Alendronate Sodium	Alendronate Sodium	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Valsartan	Valsartan	23	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Memantine Hcl Er	Memantine Hcl	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Cephalexin	Cephalexin	21	13
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Potassium Citrate Er	Potassium Citrate	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Vascepa	Icosapent Ethyl	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Colchicine	Colchicine	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Baclofen	Baclofen	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Mupirocin	Mupirocin	16	11
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Fentanyl	Fentanyl	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Nystatin	Nystatin	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Alprazolam Xr	Alprazolam	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Linzess	Linaclotide	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Torsemide	Torsemide	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Vilazodone Hcl	Vilazodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error